Skip to content

The effect of elemental diet with fluorouracil, cisplatin and leucovorin(LV+FP) in esophagus cancer patients

The effect of elemental diet with fluorouracil, cisplatin and leucovorin(LV+FP) in esophagus cancer patients - The effect of elemental diet for FPL chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014613
Enrollment
40
Registered
2014-07-22
Start date
2014-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Elental Control

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The primary tumor is located within the neck, the chest or the abdominal esophagus. 2. Pathologically proven squamous, adenosquamous or adenocarcinoma. 3. Stage 0-IV 4. 20 years old or more. 5. ECOG PS2 or less. 6. Without brain metastases. 7. Without pleural effusion, ascites. 8. Elemental diet can be administered orally or by tube feeding. 9. Naive for chemotherapy or 1 or more months have been passed after prior chemotherapy. 10. Patients underwent oral care with explamation of oral hygene. 11. Informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1. Diabetes Mellitus which requires continuous insulin administration. 2. Active double cancers. 3. Hypersensitivity for CDDP, leucovorin and 5-FU. 4. Contraindication of elental. 5. Active infections. 6. Continuous administration of steroids. 7. Neural paralysis (CTCAE v4.0 Grade1 or more). 8. Edema(CTCAEv4.0 Grade1 or more). 9. Plumonary fibrosis, pneumonitis. 10. psycholotical issues. 11. Patients enrolled in other clinical trials in which the endpoints are same. 12. Pregnant patients. 13. Inappropriate patients that doctors judged.

Design outcomes

Primary

MeasureTime frame
The rate of oral mucositis

Countries

Japan

Contacts

Public ContactYasunori Akutsu

Chiba University Department of Frontier Surgery

yakutsu@faculty.chiba-u.jp043-226-2110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026